Apoptotic cells in allogeneic hematopoietic stem cell transplantations: "turning trash into gold"

Leukemia & Lymphoma
Ilias PessachArnon Nagler

Abstract

Allogeneic hematopoietic stem cell transplantation (HST) is an important therapeutic option for various malignant and non-malignant conditions. HST during first remission offers the best cure for patients for whom conventional chemotherapy alone is not sufficient. Yet, in spite of the high curative potential and recent advances in this treatment modality, it remains limited by transplant related toxicity and grant-versus-host disease (GVHD). Apoptotic cells, which used to be regarded as immunologically "bland," are now recognized as important modulators of immune responses. Taking into account the immunological properties of apoptotic cells and the nature of the side effects of HST, they have been administered simultaneously with hematopoietic stem cells in experimental transplantation models, in anticipation of improved outcome. Under these conditions, engraftment and full-donor chimerism are facilitated without significant generation of anti-apoptotic cell auto-antibodies. In addition they prevent alloimmunization, up-regulate T regulatory cells and reduce both the frequency and the severity of GVHD. These favorable effects require host macrophages and donor bone marrow plasmatoid dendritic cells, and are associated with tumo...Continue Reading

References

Mar 7, 1991·The New England Journal of Medicine·J L Ferrara, H J Deeg
Apr 15, 1994·Cancer·J F KerrB V Harmon
Mar 4, 1993·The New England Journal of Medicine·N A KernanJ McCullough
Jul 22, 1998·The Journal of Experimental Medicine·D MevorachK B Elkon
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C Reed
Feb 9, 2000·The Journal of Experimental Medicine·R M SteinmanK Inaba
Mar 22, 2000·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·R N BarkerA J Rees
Jan 13, 2001·Current Opinion in Immunology·S Gallucci, P Matzinger
Feb 24, 2001·Annals of the New York Academy of Sciences·D Mevorach
May 5, 2001·Immunity·H A ErlichJ Hansen
May 18, 2001·Nature·F R Appelbaum
Oct 10, 2001·Current Biology : CB·P M HensonV A Fadok
Aug 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mark LucasAdam Lacy-Hulbert
May 4, 2004·Nature Reviews. Cancer·Marie Bleakley, Stanley R Riddell
Jul 23, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Sylvain PerruchePhilippe Saas
Aug 18, 2004·Current Opinion in Rheumatology·Amr H Sawalha, John B Harley
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Akira MaedaThomas Schwarz
Apr 28, 2006·The New England Journal of Medicine·Edward A Copelan
Nov 30, 2006·Annual Review of Immunology·Lisbeth A WelniakWilliam J Murphy
Jul 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Pascale LoiseauColette Raffoux
Nov 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Theresa HahnOlle Ringdén
Mar 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chun-Hong QiuMasato Tanaka
Dec 5, 2009·Nature Reviews. Immunology·Ira Tabas
May 1, 2010·Nature Reviews. Rheumatology·Luis E MuñozMartin Herrmann
Apr 5, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Francis BonnefoyPhilippe Saas
Dec 2, 2011·The New England Journal of Medicine·John KorethRobert J Soiffer

❮ Previous
Next ❯

Citations

Jul 4, 2013·Cell and Tissue Research·Megan K FullerSusan J Henning
Oct 9, 2014·Immunological Investigations·Ammar Ebrahimi, Fakher Rahim
Dec 19, 2014·PLoS Neglected Tropical Diseases·Maria C GuimaroAntonio R L Teixeira

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.